Research Archive — Page 123 of 133
-
November 12, 2015
Vanderbilt Prize winner Lindquist set for Discovery Lecture
Susan Lindquist, Ph.D., recipient of the 2014 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Lecture on Thursday, Nov. 19. -
October 29, 2015
Investigators find clues to melanoma treatment resistance
Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway. -
October 22, 2015
Study sheds light on side effects of COX-2 drugs
A team of Vanderbilt University Medical Center scientists are closer to understanding why COX-2 inhibitors — drugs that relieve arthritis pain and inflammation without the gastrointestinal side effects of other painkillers — cause heart problems in some patients. Now -
September 30, 2015
Reduced-nicotine cigarettes decreased dependence and frequency of smoking: NEJM study
Reduced-nicotine cigarettes were beneficial in reducing nicotine exposure and dependence, and also the number of cigarettes smoked per day, when compared with standard-nicotine cigarettes in a six-week study published in the New England Journal of Medicine. -
September 23, 2015
Data diving for health
To most effectively use electronic health records for research, investigators should query multiple components of the record to identify patients with specific diseases. -
August 26, 2015
Framework for studying cell responses
Vanderbilt investigators have developed a framework for studying cellular responses that could be used to identify the agents driving a range of biological processes in health and disease. -
August 20, 2015
New type of trial shows promise for several cancers
Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.